2008, ISBN 1420067494, xiv, 914
Book
2006, 7th ed., ISBN 9780849390593, xci, 1035
Book
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2811 - 2811
Background: FDG PET/CT and bone marrow biopsy (BMB) are considered standard procedures for the staging of patients with new, untreated FL. A key issue in FL is...
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5352 - 5352
Background Burkitt NHL (BL) is a rare hematologic malignancy that occurs in younger adults and is highly curable with aggressive chemoimmunotherapy induction...
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4129 - 4129
Background: Neurolymphomatosis (NL) is a highly rare disorder defined as infiltration of peripheral nervous system by a lymphoproliferative neoplasm, both...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5401 - 5401
Abstract Introduction Primary testicular lymphoma (PTL) and testicular involvement of systemic lymphoma (secondary testicular lymphoma, STL) are uncommon. Most...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4208 - 4208
Abstract Background: The majority of subjects with a diagnosis of primary central nervous system lymphoma (PCSNL) have diffuse large B-cell lymphoma (DLBCL) as...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1717 - 1717
Abstract Introduction: Clinical tumor lysis syndrome (TLS), which manifests most often as acute kidney injury (AKI) is a common and devastating complication of...
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1628 - 1628
Acute kidney injury (AKI) is common in those with newly diagnosed hematologic malignancies. Precipitants of AKI in this population may include tumor lysis...
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5215 - 5215
Purpose The development of cardiovascular disease (CVD) is a relatively rare but a clinically important adverse event in the treatment of lymphoma,...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 454 - 454
Abstract Introduction: The addition of Rituximab to chemotherapy has significantly improved the outcome of patients with newly diagnosed diffuse large B-cell...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4139 - 4139
Abstract Introduction. The peripheral blood absolute lymphocyte (ALC)/monocyte (AMC) ratio (ALC/AMC), as a surrogate of host immunity (i.e. ALC) and tumor...
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4010 - 4010
INTRODUCTION: EMZL is a heterogeneous disease with variable risk for relapse and progression. Based on age ≥70 years, stage III-IV and elevated LDH,...
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2019, Volume 60, Issue 4, pp. 920 - 926
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 09/2019, pp. 1 - 11
One-in-five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT). Given bleomycin-omission data with negative...
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1693 - 1693
Abstract MYC amplification (amp) is a marker of poor prognosis in many non-hematologic malignancies. While MYC translocations in B cell lymphoma (BCL) have...
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1750 - 1750
Abstract Introduction: "High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements" (HG DH/THL) is a new diagnosis per the revised 2016 WHO...
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 6, pp. 549 - 562
Solid-organ and hematopoietic stem-cell transplants are widely used for various life-threatening medical disorders. Prophylaxis against transplant rejection...
SOLID-ORGAN TRANSPLANTATION | VIRAL LOAD | WHOLE-BLOOD | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | RISK-FACTORS | KIDNEY-TRANSPLANTATION | INITIAL THERAPY | EBV | EPSTEIN-BARR-VIRUS | BLOOD MONONUCLEAR-CELLS | Care and treatment | Lymphoproliferative disorders | Research | Diagnosis | Epidemiology | Risk factors | Graft-versus-host reaction | Transplants & implants | Hematology | Pathogenesis | Prophylaxis | Immunoproliferative diseases | Infections | Transplantation | Patients | Hemopoiesis | Graft rejection | Immunosuppression | Lymphocytes | Lymphomas | Health risk assessment
SOLID-ORGAN TRANSPLANTATION | VIRAL LOAD | WHOLE-BLOOD | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | RISK-FACTORS | KIDNEY-TRANSPLANTATION | INITIAL THERAPY | EBV | EPSTEIN-BARR-VIRUS | BLOOD MONONUCLEAR-CELLS | Care and treatment | Lymphoproliferative disorders | Research | Diagnosis | Epidemiology | Risk factors | Graft-versus-host reaction | Transplants & implants | Hematology | Pathogenesis | Prophylaxis | Immunoproliferative diseases | Infections | Transplantation | Patients | Hemopoiesis | Graft rejection | Immunosuppression | Lymphocytes | Lymphomas | Health risk assessment
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3885 - 3885
Abstract The lymphocyte-to-monocyte ratio at diagnosis (LMR-D) has been reported to be a prognostic factor for clinical outcomes in both T-cell and B-cell...
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. E575 - E583
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.